Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2970]

Discovery of peripheral neuropathy cause suggests potential preventive measures

Discovery of peripheral neuropathy cause suggests potential preventive measures

Patient-reported outcomes for cancer survivors

Patient-reported outcomes for cancer survivors

Osimertinib granted breakthrough designation by FDA for 1st line treatment of patients with EGFRm positive NSCLC

Osimertinib granted breakthrough designation by FDA for 1st line treatment of patients with EGFRm positive NSCLC

NICE recommends access to venetoclax in England via Cancer Drugs Fund to treat most common form of adult leukaemia

NICE recommends access to venetoclax in England via Cancer Drugs Fund to treat most common form of adult leukaemia

Scientists enlist supercomputers, machine learning to automatically identify brain tumours

Scientists enlist supercomputers, machine learning to automatically identify brain tumours

Mystery of BRCA in breast cancer risk solved, 20 years after its discovery

Mystery of BRCA in breast cancer risk solved, 20 years after its discovery

Health care professional's recommendation important factor for chemoprevention decisions

Health care professional's recommendation important factor for chemoprevention decisions

New key regulator of acquisition of immune tolerance to tumour cells in cancer patients

New key regulator of acquisition of immune tolerance to tumour cells in cancer patients

Genetic test successfully detects some asymptomatic pancreatic cancers

Genetic test successfully detects some asymptomatic pancreatic cancers

CAR T cell breakthrough brings hope and challenges

CAR T cell breakthrough brings hope and challenges

More from ecancer